Bristol-Myers Squibb Company

Company Profile

Bristol-Myers Squibb Company had its IPO on 1972-01-01 under the ticker symbol BMY.

The company operates in the Healthcare sector and Drug Manufacturers-General industry. Bristol-Myers Squibb Company has a staff strength of 34,300 employees.

Stock update

Shares of Bristol-Myers Squibb Company opened at $61.01 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $59.84 - $61.02, and closed at $60.24.

This is a -0.94% slip from the previous day's closing price.

A total volume of 9,678,023 shares were traded at the close of the day’s session.

In the last one week, shares of Bristol-Myers Squibb Company have slipped by -2.87%.

Bristol-Myers Squibb Company's Key Ratios

Bristol-Myers Squibb Company has a market cap of $138.61 billion, indicating a price to book ratio of 5.1301 and a price to sales ratio of 3.4118.

In the last 12-months Bristol-Myers Squibb Company’s revenue was $45.85 billion with a gross profit of $36.38 billion and an EBITDA of $19.62 billion. The EBITDA ratio measures Bristol-Myers Squibb Company's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Bristol-Myers Squibb Company’s operating margin was 20.8% while its return on assets stood at 6.04% with a return of equity of 23.07%.

In Q1, Bristol-Myers Squibb Company’s quarterly earnings growth was a positive 81.4% while revenue growth was a negative 2.7%.

Bristol-Myers Squibb Company’s PE and PEG Ratio

Forward PE

9.9701

Trailing PE

18.9598

PEG

2.4369

Its diluted EPS in the last 12-months stands at $3.48 per share while it has a forward price to earnings multiple of 9.9701 and a PEG multiple of 2.4369. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Bristol-Myers Squibb Company’s profitability.

Bristol-Myers Squibb Company stock is trading at a EV to sales ratio of 4.2511 and a EV to EBITDA ratio of 10.291. Its price to sales ratio in the trailing 12-months stood at 3.4118.

Bristol-Myers Squibb Company stock pays annual dividends of $2.22 per share, indicating a yield of 3.53% and a payout ratio of 28.5%.

Balance sheet and cash flow metrics

Total Assets

$94.28 billion

Total Liabilities

$19.09 billion

Operating Cash Flow

$-210000000.00

Capital Expenditure

$278 million

Dividend Payout Ratio

28.5%

Bristol-Myers Squibb Company ended 2024 with $94.28 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $94.28 billion while shareholder equity stood at $31.82 billion.

Bristol-Myers Squibb Company ended 2024 with $1.57 billion in deferred long-term liabilities, $19.09 billion in other current liabilities, 292000000.00 in common stock, $26.57 billion in retained earnings and $21.16 billion in goodwill. Its cash balance stood at $9.00 billion and cash and short-term investments were $9.00 billion. The company’s total short-term debt was $2,923,000,000 while long-term debt stood at $35.08 billion.

Bristol-Myers Squibb Company’s total current assets stands at $27.09 billion while long-term investments were $2.01 billion and short-term investments were $274.00 million. Its net receivables were $13.41 billion compared to accounts payable of $3.19 billion and inventory worth $2.61 billion.

In 2024, Bristol-Myers Squibb Company's operating cash flow was $-210000000.00 while its capital expenditure stood at $278 million.

Comparatively, Bristol-Myers Squibb Company paid $0.29 in dividends in 2024.

Other key metrics

Current Trading Price

$60.24

52-Week High

$80.1412

52-Week Low

$63.07

Analyst Target Price

$79.88

Bristol-Myers Squibb Company stock is currently trading at $60.24 per share. It touched a 52-week high of $80.1412 and a 52-week low of $80.1412. Analysts tracking the stock have a 12-month average target price of $79.88.

Its 50-day moving average was $61.9 and 200-day moving average was $67.29 The short ratio stood at 2.68 indicating a short percent outstanding of 0%.

Around 7.1% of the company’s stock are held by insiders while 7861.9% are held by institutions.